Table 2.
Author, year | Research type | Study classification (laparoscopic/robotic vs. laparotomy) | Number of lymph nodes detected (n) | Negative margin rate (%) | Median survival time (months) |
---|---|---|---|---|---|
Kooby, 2010 [22] | Retrospective | 23 vs. 189 | 13.8 ± 8.4 vs. 12.5 ± 8.5 A | 74 vs. 73 | 16 vs. 16 |
Magge, 2013 [23] | Retrospective | 28 vs. 34 | 11 (8–20) vs. 12 (6–19) B | 86 vs. 88 | 19 |
Rehman, 2014 [28] | Retrospective | 8 vs. 14 | 16 (1–27) vs. 14 (0–26) C | 88 vs. 86 | 33 vs. 52 |
Shin, 2015 [25] | Retrospective | 70 vs. 80 | 12 (1–34) vs. 10 (1–64) C | 75.7 vs. 83.8 | 33.4 vs. 29.1 |
Lee, 2015 [10] | Retrospective | 23 vs. 249 | 11 ± 7.6 vs. 15 ± 8.7 A | 100 vs. 88 | N/A |
Sharpe, 2015 [29] | Retrospective | 144 vs. 625 | 14.9 ± 10.0 vs. 13.3 ± 9.9 A | 87 vs. 78 | N/A |
Stauffer, 2016 [26] | Retrospective | 44 vs. 28 | 25.9 (5–48) vs. 12.7 (1–45) B** | 95.5 vs. 82.1 | 26.6 vs. 26.4 |
Bauman, 2017 [24] | Retrospective | 33 vs. 46 | 14.5 ± 1.1 vs. 17.5 ± 1.2 A | 77 vs. 87 | 18 vs. 15 |
Raoof, 2018 [27] | Propensity score-matched | 563 vs. 563 | 12 (6–18·5) vs. 22 (14–31) B** | 85.1 vs. 81.5 | N/A |
Van Hilst, 2019 [30] | Propensity score-matched | 340 vs. 340 | 14 (8–22) vs. 22 (14–31) B* | 67 vs. 58 | 28 vs. 31 |
N/A not available
A. Results expressed as mean ± standard deviation
B. Results expressed as median (interquartile range)
C. Results expressed as median (range)
*P = 0.05; **P = 0.0001